What is the best drug-delivery approach for the acute treatment of migraine?

Expert Review of Neurotherapeutics

Volumn 12, Issue 3, 2012, Pages 253-255

  Tepper, Stewart J ^a   Stillman, Mark J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

acute treatment; drug delivery; migraine; neurostimulation; stratified care

Indexed keywords

ALSUMA; BMS 927711; CALCITONIN; CARBON DIOXIDE; DICLOFENAC; DICLOFENAC POTASSIUM; DIHYDROERGOTAMINE; DIHYDROERGOTAMINE MESILATE; KETOROLAC; KETOROLAC TROMETAMOL; LASMITIDAN; NEUROLEPTIC AGENT; NXN 188; RIZATRIPTAN; SEROTONIN 1 AGONIST; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; SUMAVEL; UNCLASSIFIED DRUG; ZELRIX;

ALLODYNIA; ANALGESIA; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; MIGRAINE; NAUSEA; NEUROMODULATION; PATIENT CARE; REVIEW; STOMACH PARESIS; SYMPTOM; TREATMENT PLANNING;

ANALGESICS; DRUG DELIVERY SYSTEMS; HUMANS; MIGRAINE DISORDERS;

EID: 84857974317     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.204     Document Type: Review

References (8)

1. Diener HC, Montagna P, Gács G et al. Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo. Cephalalgia 26(5), 537-547 (2006). (Pubitemid 43601218)
2. Lipton RB, Stewart WF, Stone AM, Láinez MJ, Sawyer JP. Disability in strategies of care study group. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) study: a randomized trial. JAMA 284(20), 2599-2605 (2000).
3. Aurora S, Kori S, Barrodale P, Nelsen A, McDonald S. Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache 47(10), 1443-1446 (2007). (Pubitemid 350209525)
4. Carpay J, Schoenen J, Ahmad F, Kinrade F, Boswell D. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study. Clin. Ther. 26(2), 214-223 (2004). (Pubitemid 38339013)
5. Tepper SJ, Kori SH, Borland SW et al. Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia. Headache 52(1), 37-47 (2012).
6. Lipton RB, Dodick DW, Silberstein SD et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 9(4), 373-380 (2010).
7. Tepper SJ, Rezai A, Narouze S, Steiner C, Mohajer P, Ansarinia M. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation. Headache 49(7), 983-989 (2009).
8. Rapoport AM, Tepper SJ, Bigal Marcelo E, Sheftell FD. The triptan formulations: how to match patients and products. CNS Drugs 17(6), 431-447(2003). (Pubitemid 36560705)